CARA Insider Trading Activity and SEC Form 4 Filings
CARA insider trading summary
No open-market insider purchases or sales of Cara Therapeutics, Inc. (CARA) have been reported on SEC Form 4 in the past 12 months.
Latest CARA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 28, 2025 | Scott Terrillion | Sec'Y; Chief Compliance & G.C. | Sell | $776 (163 @ $4.76) |
| Feb 28, 2025 | Christopher Posner | President and CEO | Sell | $3K (583 @ $4.75) |
| Feb 4, 2025 | Christopher Posner | President and CEO | Sell | $2K (372 @ $4.72) |
| Nov 4, 2024 | Christopher Posner | President and CEO | Sell | $1K (3,668 @ $0.29) |
| Aug 1, 2024 | Christopher Posner | President and CEO | Sell | $1K (4,149 @ $0.35) |
| May 2, 2024 | Christopher Posner | President and CEO | Sell | $3K (3,936 @ $0.75) |
| Apr 5, 2024 | Joana Goncalves | Chief Medical Officer | Sell | $2K (2,753 @ $0.83) |
| Apr 5, 2024 | Scott Terrillion | Sec'Y; Chief Compliance & G.C. | Sell | $2K (2,753 @ $0.83) |
| Feb 29, 2024 | Joana Goncalves | Chief Medical Officer | Sell | $3K (3,293 @ $0.89) |
| Feb 29, 2024 | Christopher Posner | President and CEO | Sell | $5K (5,834 @ $0.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.